Paraguay's IPS Restocks 347 Key Medications After Critical Shortage

The Paraguayan Institute of Social Security (IPS) has successfully replenished its stock, distributing 347 types of essential medications, medical supplies, and devices to 110 pharmacies across the country. This move aims to end a critical shortage that began in March, when the IPS admitted to a severe lack of 154 basic medications, 102 of which were deemed urgent or vital.

To combat the "stock zero" crisis, the institution launched a contingency plan centered on public tenders. The IPS reported that medication availability was restored between April 23 and June 3, 2026. Patients with complex conditions, including cancer and diabetes, are among the primary beneficiaries. The replenished stock includes oncological drugs like Bevacizumab and Daratumumab, as well as essential diabetes treatments such as various insulin types and oral medications like Metformin and Dapagliflozin.

The supply of cardiovascular and antihypertensive medications, vital for daily consultations, has also been normalized, with drugs like Enalapril and Losartan now available. Respiratory medications, including Budesonide and Salbutamol, are back in stock for winter ailments. The distribution also covers gastric care, vitamins, and critical supplies for anesthesia, hemodynamics, and hemodialysis, signaling a significant improvement in the availability of essential medical provisions.